Company Filing History:
Years Active: 2002
Title: Meija Yang: Innovator in Protein Complexes
Introduction
Meija Yang is a prominent inventor based in East Lyme, Connecticut. She has made significant contributions to the field of protein research, particularly through her innovative work on the NLK1 protein and its complexes. Her research has implications for treating various diseases and disorders.
Latest Patents
Meija Yang holds a patent for the NLK1 protein and NLK1 protein complexes. The present invention discloses complexes of the Nlk1 protein with proteins identified as interacting with the Nlk1 protein (Nlk1 protein-IPs) by a modified, improved yeast two-hybrid assay system. The proteins identified to interact with the Nlk1 protein include TrkA, protein phosphatase 1α, 14-3-3ε, α-tropomyosin, vimentin, p0071, Ini-1, IP-1, IP-2, IP-3, IP-4, and IP-5, as well as derivatives, fragments, analogs, and homologs thereof. Methodologies for screening these complexes for efficacy in treating and/or preventing various diseases, particularly neoplasia, neurodegenerative diseases, hypertrophic cardiomyopathy, viral infections, and metabolic diseases, are also disclosed.
Career Highlights
Meija Yang is currently associated with Curagen Corporation, where she continues her research and development in protein complexes. Her work has garnered attention for its potential applications in medical science.
Collaborations
Meija has collaborated with notable colleagues, including Krishnan Nandabalan and Vincent Peter Schulz, to advance her research initiatives.
Conclusion
Meija Yang's innovative work on the NLK1 protein and its complexes represents a significant advancement in the field of protein research. Her contributions have the potential to impact the treatment of various diseases and disorders, showcasing her role as a leading inventor in this area.